Parkinson's Disease Disrupts the Brain's Enkephalin System — And Dopamine Drugs Don't Fix It | Research

The takeaway

Parkinson's patients have significantly low cerebrospinal fluid enkephalin levels that are not restored by levodopa treatment, suggesting opioid peptide disruption contributes to symptoms beyond dopamine deficiency.

Enkephalin levels: significantly low
CSF MERGL levels in Parkinson's patients were significantly below normal and not restored by levodopa infusion

What the researchers found

Cerebrospinal fluid MERGL levels were significantly low in Parkinson's patients after overnight medication withdrawal. Steady-state levodopa infusion did not restore them.

Why it matters

This study shows that Parkinson's disease affects more than just dopamine. The enkephalin system, which plays a role in movement control and pain, is also disrupted. This could help explain some symptoms that dopamine drugs do not fix.

How the study worked

Brain fluid was collected from Parkinson's patients after overnight medication withdrawal and again during intravenous levodopa infusion. MERGL levels were compared to healthy controls.

What this study cannot tell us

Small sample of patients. Cross-sectional design cannot prove cause and effect. Brain fluid levels may not perfectly reflect what is happening inside specific brain regions.

How to read the evidence

Preliminary cross-sectional study with small sample size. CSF measurements provide relevant biomarker data but cannot prove causation.

When this study was published

Published in 1991. Non-dopaminergic neurotransmitter disruption in Parkinson's is now well-recognized and guides research into new therapies.

The bigger picture

This finding suggests that Parkinson's disease involves more than just dopamine loss. The disrupted enkephalin system may contribute to common Parkinson's symptoms that don't respond well to dopamine drugs, including pain, depression, and certain movement difficulties. This could open new therapeutic targets.

Questions still open

Could enkephalin-enhancing drugs improve Parkinson's symptoms that levodopa misses?
Do enkephalin levels predict Parkinson's disease severity or progression?

Common questions

Why don't dopamine drugs fix the enkephalin problem?

Enkephalin-producing neurons in the basal ganglia may be independently damaged in Parkinson's disease, not just responding to low dopamine. Simply adding dopamine back cannot restore damaged enkephalin neurons.

What symptoms might low enkephalin explain?

Many Parkinson's patients experience pain, depression, and anxiety that don't fully respond to dopamine drugs. Low enkephalin levels could contribute to these symptoms since enkephalins modulate pain and mood.

Read the original research

Opioid peptides in Parkinson's disease: effects of dopamine repletion.

Brain research, 560(1-2), 92-6

View on PubMed ↗

Citation

Baronti, F; Conant, K E; Giuffra, M; Davis, T L; Brughitta, G; Iadarola, M J; Berrettini, W H; Chase, T N; Mouradian, M M. (1991). Opioid peptides in Parkinson's disease: effects of dopamine repletion.. Brain research, 560(1-2), 92-6.